跳至主要内容
临床试验/NCT00921700
NCT00921700已完成4 期

Analgesic Effect of Ibuprofen 400 mg/Paracetamol 1000 mg, Ibuprofen 400 mg/ Paracetamol 1000 mg/60 mg Codeine, and Paracetamol 1000 mg/Codeine 60 mg: A Single-dose, Randomized, Placebo-controlled and Double-blind Study

Ullevaal University Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2009年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
200
试验地点
1
主要终点
Sum pain intensity SPI (0-10 Numerical Rating Scale)

研究概览

简要总结

The purpose of this study is to determine whether the combination of paracetamol (acetaminophen) and other NSAIDs with or without weak opioids can give synergistic analgesic effect.

详细描述

Combining paracetamol and other NSAIDs could give a theoretical synergistic analgesic effect according to already known or assumed mechanisms of action. Synergism is defined as an additive or supra-additive effect not achieved by one of the drugs alone. Such synergism is shown in clinical studies between acetaminophen and naproxen in coxarthrosis and rheumatoid arthritis. Later, a significant additive effect of 100 mg diclofenac with 1 g acetaminophen was demonstrated in a dental pain model.

One review article conclude that acetaminophen and NSAIDs may be appropriate to combine, and the combination is superior to acetaminophen, but not to NSAIDs alone. This view is contested by another review article which concludes that paracetamol may enhance the analgesic effect when added to an NSAID. In both reviews the authors also state that the clinical trials are too few, with different drug formulations, and different pain models not allowing definite conclusions.

There seems to be a need for studies investigating the potential synergistic effects of paracetamol combined with another NSAID displaying similar pharmacokinetic characteristics. To the best of our knowledge no published study has investigated the analgesic effect of the combination of ibuprofen and paracetamol, ibuprofen and paracetamol + codeine versus placebo (i.e. negative control to adjust for possible analgesic placebo effects) and the best standard analgesic treatment (i.e. paracetamol + codeine) as a positive control group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients of ASA class I in need of surgical removal of impacted third molars and with at least moderate postoperative pain as defined by subjective score on a verbal rating scale after surgical removal of third molars.

排除标准

  • Females stating not suspected or not verified pregnancy after being questioned by investigator.
  • Patients who have used analgesics for 3 days prior to the day of surgery.
  • Patients with known active gastrointestinal bleeding or ulcer.
  • Patients with any known hypersensitivity to NSAIDs.
  • Patients with other drug treatment than contraceptives.
  • Patients smoking before taking the test-drug or during the observation period.
  • Drug addicts or rehabilitated drug addicts.
  • Patients with surgery time exceeding 60 minutes
  • Peroperative complications such as profuse bleeding or perforation to the maxillary sinus requiring additional drug treatment during or after the surgical removal of the third molar.
  • Postoperative complications such as extended bleeding, nausea and regurgitation during the observation period.

研究组 & 干预措施

Ibuprofen + Paracetamol

Experimental

Single oral dose of ibuprofen 400 mg + paracetamol (acetaminophen) 1000 mg

干预措施: Ibuprofen + Paracetamol (Drug)

Ibuprofen + Paracetamol + Codeine

Experimental

Single oral dose of ibuprofen 400 mg + paracetamol (acetaminophen) 1000 mg + codeine 60 mg

干预措施: Ibuprofen + Paracetamol + Codeine (Drug)

Paracetamol + Codeine

Active Comparator

Single oral dose of paracetamol (acetaminophen) 1000 mg + codeine 60 mg

干预措施: Paracetamol + Codeine (Drug)

Placebo

Placebo Comparator

Single oral dose of lactose as placebo

干预措施: Placebo (Drug)

结局指标

主要结局

Sum pain intensity SPI (0-10 Numerical Rating Scale)

时间窗: 6 hours

次要结局

  • Overall assessment of efficacy (4-point Verbal Rating Scale)(6 hours)
  • Adverse effects AE (Specific reporting of AE - type, duration and severity)(6 hours)
  • Sum pain intensity difference score (PID)(6 hours)

研究者

发起方
Ullevaal University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Lasse Ansgar Skoglund

Professor

Oslo University Hospital

研究点 (1)

Loading locations...

相似试验